Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

• Status: Completed
• Trial end date: 2012-10-01

Summary

The current study is initiated in order to assess the impact of a PD solution containing L-carnitine on insulin sensitivity measured by a hyperinsulinemic euglycemic clamp.

• Phase: Phase 2

Details

• Lead Sponsor: Iperboreal Pharma Srl
• Treatments: Insulin; Pharmaceutical Solutions